Edition:
United Kingdom

CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

0.47USD
14 Dec 2018
Change (% chg)

$-0.03 (-5.39%)
Prev Close
$0.50
Open
$0.50
Day's High
$0.50
Day's Low
$0.47
Volume
9,813
Avg. Vol
20,432
52-wk High
$2.35
52-wk Low
$0.47

Chart for

About

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)

Overall

Beta: 2.34
Market Cap(Mil.): $69.25
Shares Outstanding(Mil.): 165.83
Dividend: --
Yield (%): --

Financials

  CYTR.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.41 -- --
ROI: -112.76 9.01 14.96
ROE: -214.05 10.15 16.52

Earnings vs. Estimates